• The Big Idea Behind Big Data

    NPR.org | As we find our way in a world shaped by Big Data, it's not the reams of information we gather but the networks they illuminate that's the newest addition to science's index of things.

    Nov 17, 2017

  • In Search For Alzheimer's Drugs, Researchers Must Go Beyond Beta Amyloid

    STAT | In the search for Alzheimer's drugs, it's time to pay more attention to drugs that go beyond targeting beta amyloid, a protein linked to the disease.

    Nov 17, 2017

  • African scientists get their own open-access publishing platform

    Nature News & Comment | Venture will launch next year and seeks to strengthen continent's science by helping academics share work more quickly.

    Nov 15, 2017

  • US Scientists Try 1st Gene Editing In The Body

    AP News | Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease.

    Nov 15, 2017

  • Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx And Expanded Use Of MiSeqDx

    Bio-IT World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.

    Nov 15, 2017

  • Genomics’ Role In Global Pathogen Surveillance, Diagnosis

    Bio-IT World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.

    Nov 14, 2017

  • Wiping Out Alzheimers Is Personal To Microsofts Bill Gates And Paul Allen

    Forbes | Bill Gates announced today that he will invest $50 million of his own money in the Dementia Discovery Fund. Gates has a different approach to funding Alzheimer's research than does Allen, his Microsoft co-founder, but the two are similar in their motives and beliefs about what it's going to take to conquer the disease.

    Nov 13, 2017

  • America Just Can’t Match China’s Exploding Supercomputing Power

    MIT Technology Review | What's up in emerging technology, including China's exploding supercomputing power.

    Nov 13, 2017

  • Transforming Information Into Knowledge In The Big Data Era

    Bio-IT World Contributed Commentary | Despite the overwhelming volume and complexity of scientific literature, and the myriad ways of accessing and managing it, the success of an entire research organization may depend on quick, efficient, cost-effective, and unfettered access to the information contained in reference publications. So, how do biomedical and drug discovery researchers effectively transform information into useful knowledge in the Big Data era?

    Nov 13, 2017

  • Struggling GSK Recruits Cancer Drug Guru Hal Barron As Its New R&D Chief

    ENDPOINTS | GlaxoSmithKline has recruited Hal Barron, one of the world's top cancer drug investigators, to take the helm of its troubled pharma R&D group, offering a fresh sign that the pharma giant is jumping back in a big way into oncology.

    Nov 9, 2017

  • DDN Partners With Hewlett Packard Enterprise To Deliver Unmatched HPC Storage Solutions

    Bio-IT World Brief | DDN has entered into a partnership with Hewlett Packard Enterprise (HPE) to integrate DDN’s parallel file system storage and flash storage cache technology with HPE’s HPC platforms. The focus of the partnership is to accelerate and simplify customers’ workflows in technical computing, artificial intelligence and machine learning environments.

    Nov 9, 2017

  • Build The Ebola Database In Africa

    Nature | To build trust, capacity and utility, put local researchers in charge of planned platform, says Brian Conton.

    Nov 8, 2017

  • Artificial Intelligence & Real World Data: The Next Steps In Your Big Data Journey

    Bio-IT World Contributed Commentary | KPMG’s CEO Survey found that some of the largest U.S. life sciences companies are sending mixed signals about their commitment to technology and trailing other industries in their plans to adopt cutting edge technologies.

    Nov 8, 2017

  • What Happens When You Put 500,000 Peoples DNA Online

    The Atlantic | Huge genetic databases are changing how scientists study disease.

    Nov 7, 2017

  • NIH Launches Data Commons Pilot With 9 Projects

    Bio-IT World Brief | Yesterday the National Institutes of Health announced twelve awards totaling $9 million in Fiscal Year 2017 to launch a National Institutes of Health Data Commons Pilot Phase. The NIH Data Commons will be implemented in a four-year pilot phase to explore the feasibility and best practices for making digital objects available through cloud-based collaborative platforms.

    Nov 7, 2017

  • Why Thomson Reuters' Introduction Of Enterprise Graph Analytics To Its Global Customers Is A Big Deal For Big Data

    International Business Times UK | Older technology hasn't been able to keep up with data volumes and demand for insights; Cambridge Semantics' Sean Martin explains why business should sit up and take notice.

    Nov 6, 2017

  • Seven Bridges Leads Public-Private Partnership To Develop New Data Ecosystem For NIH

    Bio-IT World Brief | Seven Bridges today announced that it has been selected by the NIH to support the NIH Data Commons Pilot Phase. The Data Commons Pilot Phase is NIH’s latest effort to accelerate biomedical research through informatics. Seven Bridges will lead a team consisting of Repositive, Elsevier, and the Boston Veterans Affair Research Institute. Together, they are forming a private-public consortium called FAIR4CURES.

    Nov 6, 2017

  • Josh Denny On The All Of Us Research Program, Data Management On A National Scale

    Bio-IT World | Vanderbilt University has been biobanking patient specimens since 2007 when Josh Denny launched BioVU. Today, the biobank has nearly 250,000 samples, some of which have associated medical records dating back to the early 1980s. Josh Denny, who leads the All of Us Research Program Data and Research Center, hopes the Precision Medicine Initiative will empower the same kind of studies.

    Nov 6, 2017

  • What It's Really Like To Fundraise From Silicon Valley's VCs

    CNBC | So-called biotech rebel Ethan Perlstein describes fundraising as a whole lot of rejections and "crippling self-doubt," but he got through it. Here are the three biggest lessons he learned.

    Nov 3, 2017

  • A New Class: Protein-Protein Interactions As Drug Targets

    Bio-IT World | Since the onset of targeted drug discovery, a little before the turn of the millennium, intracellular drug targets have primarily been enzymes that catalyze reactions. However, a new type of intracellular drug target—Protein-Protein Interactions—are now expanding the space in which to search for new types of medicines.

    Nov 3, 2017